Tactile Medical
Tactile Medical (NASDAQ: TCMD) develops and markets FDA-cleared at-home pneumatic compression devices (Flexitouch Plus, Nimbl, Entre Plus) and the AffloVest HFCWO airway clearance system, serving U.S. patients with lymphedema, lipedema, chronic venous insufficiency, and chronic respiratory conditions through prescription-based sales reimbursed by Medicare, the VA, and commercial health plans.
- Company typePublic
- Founded1995
- HeadquartersMinneapolis, United States
- Headcount251–500
- GTM typeB2C
- OfferingHardware or Manufacturing
What Tactile Medical does
Tactile Medical (legal name Tactile Systems Technology, Inc.; NASDAQ: TCMD) is a Minneapolis-based medical technology company that develops, manufactures, and markets at-home pneumatic compression therapy systems and high-frequency chest wall oscillation (HFCWO) airway clearance devices. Its portfolio targets chronic conditions including lymphedema (primary, secondary, head and neck, and lipedema-related), chronic venous insufficiency (CVI), nonhealing venous leg ulcers, and chronic respiratory disorders such as cystic fibrosis, bronchiectasis, and neuromuscular disease. The company estimates the U.S. patient population at more than 20 million Americans affected by chronic swelling, including up to 40% of breast cancer survivors who develop lymphedema. Headcount is reported in the 251–500 range.
The core technology centers on proprietary multi-chambered intermittent pneumatic compression (IPC) garment systems — Flexitouch Plus (HCPCS E0652), Nimbl (HCPCS E0651), and the legacy Entre Plus — that deliver sequenced, wave-like pressure to mimic manual lymphatic drainage and stimulate lymphatic circulation. AffloVest, acquired from International Biophysics Corporation in September 2021, provides HFCWO airway clearance and received FDA 510(k) clearance for a next-generation connected version launching in June 2026. The ComfortEase garment line (zippers, numbered tabs, thinner fabric) was rolled out for lower extremity in June 2022 and upper extremity in June 2023. The Kylee mobile app (iOS/Android) pairs via Bluetooth with Flexitouch Plus and Nimbl to log treatments, track symptoms, and produce shareable clinician reports. The February 2026 acquisition of LymphaTech Inc. for $6.8M upfront adds 3D scanning technology for lymphedema assessment and monitoring. Clinical evidence cited includes 19+ clinical studies, 24+ peer-reviewed articles, and 1,800+ studied patients, with reported outcomes such as 88% (lower body) and 95% (upper body) limb volume reduction and 97% of head and neck patients reporting softer fibrotic tissue.
The business model is prescription-based, durable medical equipment (DME) reimbursed by Medicare, the Veterans Affairs Federal Supply Schedule (FSS 36F79718D0519), and commercial health plans covering more than 270 million lives. Tactile Medical monetizes primarily through one-time device sales (hardware), with accessory e-commerce (bags, batteries, garment pads) at shop.tactilemedical.com as a secondary, non-reimbursed stream; reimbursement and patient advocacy services are bundled into device revenue. Go-to-market combines enterprise-style direct field sales to clinicians (with digital ordering via Parachute Health), direct-to-patient fulfillment with in-home fitting and training, and a dedicated VA channel. FY2025 revenue of approximately $329.5M grew to Q1 2026 revenue of $75.3M (+23% YoY); FY2026 guidance was raised to $360–$368M with adjusted EBITDA of $49–$51M and gross margin reaching 76.5% in Q1 2026.
Tactile Medical firmographics
Firmographics- Name
- Tactile Medical
- Legal name
- Tactile Systems Technology, Inc.
- Website
- https://tactilemedical.com
- Company type
- Public
- Founded year
- 1995
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Tactile Medical (NASDAQ: TCMD) develops and markets FDA-cleared at-home pneumatic compression devices (Flexitouch Plus, Nimbl, Entre Plus) and the AffloVest HFCWO airway clearance system, serving U.S. patients with lymphedema, lipedema, chronic venous insufficiency, and chronic respiratory conditions through prescription-based sales reimbursed by Medicare, the VA, and commercial health plans.
- Ownership category
- akta.pro rank
Tactile Medical industry classification
Industry- Product category
- At-home pneumatic compression therapy devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)
- akta.pro secondary industries
- Compression Therapy for Venous/Lymphedema (Bandages, Wraps, Garments) (HLAHALAF), Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Drug Delivery Connectivity, Sensors & Digital Add-Ons (Smart Caps/Companion Apps) (HLAHAIAM), Durable Medical Equipment (DME) Sales & Rentals (HSABAKAA)
Keywords
Where Tactile Medical is headquartered
LocationHeadquarters
- HQ city
- Minneapolis
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Tactile Medical business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain, Others
Revenue model
- Pneumatic compression device sales: Primary revenue stream from sale of Flexitouch Plus, Nimbl, Entre Plus, and AffloVest systems reimbursed by Medicare, Veterans Affairs, and commercial health plans representing more than 270 million lives. Devices are prescription-based and typically one-time purchases per patient.
- Accessories sales via online storefront: Direct e-commerce sales of accessories including travel bags, rechargeable batteries, power cords, and replacement garment pads through shop.tactilemedical.com. Items are not eligible for insurance reimbursement and require credit card payment.
- Reimbursement and patient advocacy services: Value-add service bundled with device sales: experienced reimbursement specialists streamline insurance navigation, prior authorizations, and appeals for patients, included as part of the total cost of the prescribed device.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Insurance-reimbursed DME (Flexitouch Plus, Nimbl, Entre Plus, AffloVest) |
| One time/ perpetual license | Pay-as-you-go | Accessories e-commerce (bags, batteries, garment pads) |
Go-to-market motion4 records
Distribution channels5 records
Marketing channels8 records
Tactile Medical product offering
Product offeringCore offering
Tactile Medical develops, manufactures, and distributes at-home pneumatic compression therapy devices (Flexitouch Plus, Nimbl, Entre Plus) for the treatment of lymphedema, lipedema, and chronic venous insufficiency, plus the AffloVest high-frequency chest wall oscillation airway clearance system for chronic respiratory conditions. Devices are prescription-based durable medical equipment reimbursed by Medicare, Veterans Affairs, and commercial health plans, and are complemented by the Kylee Bluetooth-connected patient mobile app and accessories sold direct via the company's e-commerce storefront.
Product overview
Tactile Medical is a single-vendor medical technology company that develops and markets an integrated portfolio of at-home pneumatic compression therapy products for chronic disorders, principally lymphedema, lipedema, chronic venous insufficiency (CVI), and chronic respiratory conditions. The portfolio is built around the core Flexitouch Plus advanced pneumatic compression system (HCPCS E0652) and the Nimbl basic pneumatic compression system (HCPCS E0651), supported by the legacy Entre Plus system, the AffloVest high-frequency chest wall oscillation airway clearance system, the redesigned ComfortEase garment line for Flexitouch Plus, and the Kylee Bluetooth-connected companion mobile app for symptom tracking and treatment sharing. The acquisition of LymphaTech adds 3D scanning technology for lymphedema assessment and monitoring, extending the offering from discrete products toward an integrated digital lymphedema solutions platform with connected care and remote monitoring capabilities.
Differentiator
Problem solved
Functional benefit
Brands
- Flexitouch: Advanced intermittent pneumatic compression device system (including Flexitouch Plus) clinically proven for at-home self-management of lymphedema and nonhealing venous leg ulcers. Includes head/neck, upper body, and lower body garment variants with the ComfortEase garment line.
- Nimbl
- Kylee
- AffloVest
- Entre Plus
- ComfortEase
Products and services
- Flexitouch Plus System Advanced intermittent pneumatic compression device (HCPCS E0652) that stimulates the lymphatic system for at-home self-management of lymphedema, chronic venous insufficiency (CVI), and nonhealing venous leg ulcers. Available with region-specific ComfortEase garments for head and neck, upper body, and lower body treatment.
- Nimbl System Compact, Bluetooth-connected pneumatic compression device (HCPCS E0651) with a small, light controller and eight sequential compression chambers for upper and lower body treatment of lymphedema and CVI. Pairs with the Kylee app for treatment tracking.
- AffloVest High-frequency chest wall oscillation (HFCWO) airway clearance vest system for patients with chronic respiratory conditions including cystic fibrosis, bronchiectasis, COPD, and neuromuscular disorders. Gently loosens and mobilizes mucus for easier clearance at home or on the go.
- Entre Plus System Intermittent pneumatic compression device (HCPCS E0651) for upper and lower body treatment of lymphedema. Supports approximately 60-minute treatment sessions in single-garment and bilateral configurations. Predecessor to the Nimbl product line.
- Kylee App Free mobile app (iOS 18+ and Android 14+) for lymphedema and chronic swelling self-management. Connects via Bluetooth to Flexitouch Plus and Nimbl devices to track daily symptoms (swelling, pain, heaviness), log treatments, set reminders, monitor order status, and generate shareable activity reports of up to six months of history for healthcare teams.
- Tactile Medical Accessories Direct-to-consumer e-commerce accessories (travel bags, rechargeable batteries, power cords, replacement garment pads) sold via shop.tactilemedical.com with FedEx Ground shipping, 60-day return window on unopened items, and credit card payment.
Quantifiable outcome
- 88% of patients experience limb volume reduction with Flexitouch Plus lower body treatment
- +5 more outcomes
Companies that use Tactile Medical
Customer profileNamed customers5 records
Segments5 records
Ideal customer profiles5 records
Tactile Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature6 records
Tactile Medical partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- LymphaTech Inc.coreTactile Medical acquired LymphaTech Inc. for $6.8 million in upfront cash (with potential milestone-based payments) to enhance its portfolio in lymphedema solutions and digital care. LymphaTech is a privately held medical technology company pioneering 3D scanning technology for assessing and monitoring lymphedema patients, supporting Tactile Medical's evolution from a product-based company to an integrated lymphedema solutions leader. Integration is progressing as planned, with GUIDE grant revenue incorporated into the fiscal outlook.
- International Biophysics CorporationcoreTactile Medical acquired AffloVest from International Biophysics Corporation on September 8, 2021, to expand its treatment offerings for chronic respiratory conditions. The deal supports the company's growth and margin targets, including a 20%+ revenue increase and gross margins above 70%. The acquisition contributed significantly to Tactile Medical's revenue and profitability, with airway clearance revenue growing 66% YoY in Q4 2025.
- Parachute HealthcoreTactile Medical partnered with Parachute Health to offer digital pneumatic compression device ordering at no cost to clinicians. The platform provides a guided 5-step ordering process meeting insurance requirements, real-time communication with Tactile Medical, one-click digital signatures, and visibility into patient order status with real-time updates. Replaces/augments traditional fax-based ordering.
- U.S. Department of Veterans Affairs (VA)coreTactile Medical is listed on the VA Federal Supply Schedule (36F79718D0519), allowing the company to provide pneumatic compression devices to Veterans for management of chronic swelling and venous insufficiency at home. Local representatives assist VA healthcare teams with patient selection, measuring, and in-home training. VA covers full device cost with no Veteran copay. NPI: 1427131424, DUNS: 146295980.
Scale indicators11 records
Recent moves6 records
Expansion highlights7 records
Tactile Medical competitors and assessment
Company assessmentDirect peers
- Arjo AB: Swedish-listed medical device company with a dedicated DVT/pneumatic compression portfolio (e.g., Flowtron) and the largest sequential compression system share in Europe (18–20%). Directly comparable product category, target patient populations (lymphedema, DVT prophylaxis, CVI), and reimbursement-driven DME business model.
- BioCompression Systems: U.S. medical device manufacturer specializing in pneumatic compression pumps (e.g., Sequential Circulator, Lympha Press) for lymphedema, venous insufficiency, and wound care. Closely aligned product offering, clinical indications, and reimbursement-driven DME go-to-market.
- Devon Medical Products: Specialty DME manufacturer of intermittent pneumatic compression devices for DVT prophylaxis and lymphedema. Smaller scale than Tactile Medical but competes in the same HCPCS-coded product categories with a similar clinician-driven prescription model.
- Electromed: U.S. medical device company focused exclusively on high-frequency chest wall oscillation (HFCWO) airway clearance systems (SmartVest), directly competing with AffloVest in cystic fibrosis, bronchiectasis, and neuromuscular respiratory indications. Single-product company with similar reimbursement-driven DME model.
Broad incumbents
- Cardinal Health: U.S. healthcare distributor and medical products company with at-Home Solutions and DME businesses covering compression, ostomy, and urological products. Operates a broader portfolio across distribution, at-home medical, and acute care, with 12–14% share of the European sequential compression market as a competitor to Tactile Medical.
- Enovis Corporation (DJO): Medical technology company with a strong DME and orthopedic bracing portfolio (DJO, Aircast, DonJoy), addressing recovery, lymphedema, and rehabilitation through clinician channels. Broader portfolio than Tactile Medical but overlapping patient populations and durable medical equipment distribution model.
- Hillrom (Baxter International): Baxter's Patient Support Systems business (acquired via Hillrom) includes the MetaTherapy/Volara and The Vest HFCWO airway clearance systems, directly comparable to AffloVest. Large incumbent with hospital and home-channel reach into respiratory and chronic care DME.
- Owens & Minor: U.S. medical products distribution and Patient Direct (home healthcare) company, including Apria Healthcare following the 2022 acquisition. Broad DME distribution and at-home medical equipment platform overlapping Tactile Medical's direct-to-patient fulfillment model.
- Integra LifeSciences: Diversified medical technology company with tissue regeneration, neurosurgery, and ENT businesses, including products serving chronic wound, lymphedema-adjacent, and home-care channels. Broader portfolio but comparable mid-cap public medtech scale and clinician-driven specialty distribution model.
Regional players
- Mego Afek Ltd. Israel-based manufacturer of Lympha Press sequential and pneumatic compression systems distributed internationally. Directly comparable product technology and lymphedema/venous indications; primarily serves non-U.S. markets where Tactile Medical has limited share.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Tactile Medical social profiles
Digital presenceTactile Medical compliance and trust
Trust signalCompliance2 records
Tactile Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Tactile Medical leadership team
Management profileNumber of profiles
Profiles3 records
Tactile Medical subsidiaries and ownership
Company hierarchySubsidiaries2 records
Tactile Medical funding detail
Funding detailFunding overview
Funding rounds4 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Tactile Medical M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Tactile Medical
What does Tactile Medical do?
Tactile Medical develops, manufactures, and distributes at-home pneumatic compression therapy devices (Flexitouch Plus, Nimbl, Entre Plus) for the treatment of lymphedema, lipedema, and chronic venous insufficiency, plus the AffloVest high-frequency chest wall oscillation airway clearance system for chronic respiratory conditions. Devices are prescription-based durable medical equipment reimbursed by Medicare, Veterans Affairs, and commercial health plans, and are complemented by the Kylee Bluetooth-connected patient mobile app and accessories sold direct via the company's e-commerce storefront.
Is Tactile Medical a public or private company?
Tactile Medical is a public company. It is classified as public and is currently operating.
When was Tactile Medical founded?
Tactile Medical was founded in 1995. It employs 251 to 500 people.
Where is Tactile Medical based?
Tactile Medical is headquartered in Minneapolis, United States, in the North America region.
How does Tactile Medical make money?
Three revenue lines are on record. Pneumatic compression device sales are the primary driver. The others are accessories sales via online storefront and reimbursement and patient advocacy services.
Who are Tactile Medical's main competitors?
Direct peers on record are Arjo AB, BioCompression Systems, Devon Medical Products and Electromed. Broad incumbents are Cardinal Health, Enovis Corporation (DJO), Hillrom (Baxter International), Owens & Minor and Integra LifeSciences. Mego Afek Ltd. is listed as a regional player.
Does Tactile Medical have an API?
No public API is recorded for Tactile Medical.
What industry is Tactile Medical in?
Tactile Medical's product category is At-home pneumatic compression therapy devices. Its primary akta.pro industry code is HLAHAMAG, Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices), with a secondary code of HLAHALAF, Compression Therapy for Venous/Lymphedema (Bandages, Wraps, Garments). Its NAICS code is 339113 and its SIC code is 3841.